EP2710032
Umbreytt glýkóprótín
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
18.5.2012EP published:
25.12.2019EP application number:
12790362.3
EP translation filed:
22.1.2020Grant published:
15.2.2020EPO information:
European Patent Register
Max expiry date:
17.5.2032
Title:
MODIFIED GLYCOPROTEINS
Timeline
Today
18.5.2012EP application
25.12.2019EP Publication
22.1.2020Translation submitted
15.2.2020Registration published
Owner
Name:
Momenta Pharmaceuticals, Inc.Address:
301 Binney Street, Cambridge, MA 02142, US
Inventor
Name:
BULIK, Dorota, A.Address:
Malden, MA 02148, US
Name:
BOSQUES, Carlos, J.Address:
Arlington, MA 02476, US
Name:
COLLINS, Brian, EdwardAddress:
Arlington, MA 02474, US
Name:
HAINS, Maurice, GastonAddress:
Brockton, MA 02301, US
Name:
WASHBURN, Nathaniel, J.Address:
Littleton, MA 01460, US
Name:
MEADOR, JamesAddress:
Framingham, MA 01702, US
Name:
SMITH, SeanAddress:
Littleton, MA 01460, US
Name:
BHATNAGAR, NaveenAddress:
Framingham, MA 01702, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161488523 PDate:
20.5.2011Country:
US
Number:
201261638134 PDate:
25.4.2012Country:
US
Classification
Categories:
C07K 16/00, C12P 21/08